NORTHERN TRUST CORP - ASSERTIO THERAPEUTICS INC ownership

ASSERTIO THERAPEUTICS INC's ticker is ASRT and the CUSIP is 04545L107. A total of 1 filers reported holding ASSERTIO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ASSERTIO THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$492,000
-46.8%
757,186
+2.4%
0.00%
Q4 2019$924,000
-12.4%
739,390
-10.3%
0.00%
Q3 2019$1,055,000
-60.9%
824,061
+5.3%
0.00%
-100.0%
Q2 2019$2,699,000
-33.4%
782,300
-2.1%
0.00%0.0%
Q1 2019$4,051,000
+40.3%
798,902
-0.1%
0.00%0.0%
Q4 2018$2,887,000
-40.9%
799,485
-3.8%
0.00%0.0%
Q3 2018$4,889,000831,4090.00%
Other shareholders
ASSERTIO THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 120,600$416,0000.29%
Matarin Capital Management, LLC 762,489$2,631,0000.19%
DELTEC ASSET MANAGEMENT LLC 204,513$706,0000.16%
GLOBEFLEX CAPITAL L P 213,991$738,0000.15%
TSP Capital Management Group, LLC 88,750$306,0000.14%
Spark Investment Management LLC 512,500$1,768,0000.12%
OXFORD ASSET MANAGEMENT LLP 1,141,332$3,938,0000.08%
ALGERT GLOBAL LLC 66,842$231,0000.08%
CIGNA INVESTMENTS INC /NEW 188,018$645,0000.07%
Connor, Clark & Lunn Investment Management Ltd. 3,103,949$10,709,0000.07%
View complete list of ASSERTIO THERAPEUTICS INC shareholders